We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$127M
AUM Growth
+$6.18M
Cap. Flow
-$1.32M
Cap. Flow %
-1.04%
Top 10 Hldgs %
33.49%
Holding
553
New
80
Increased
86
Reduced
113
Closed
64

Sector Composition

Rank Sector Weight
1 Technology 7.09%
2 Healthcare 4.61%
3 Industrials 3.9%
4 Financials 3.83%
5 Consumer Discretionary 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATR icon
401
AptarGroup
ATR
$8.57B
$3.3K ﹤0.01%
30
MRVL icon
402
Marvell Technology
MRVL
$191B
$3.3K ﹤0.01%
89
PRTA icon
403
Prothena Corp
PRTA
$473M
$3.01K ﹤0.01%
50
AWK icon
404
American Water Works
AWK
$27B
$2.9K ﹤0.01%
19
SCHC icon
405
Schwab International Small-Cap Equity ETF
SCHC
$5.65B
$2.83K ﹤0.01%
90
VCYT icon
406
Veracyte
VCYT
$3.73B
$2.8K ﹤0.01%
118
+78
+195% +$1.81K
SHOP icon
407
Shopify
SHOP
$196B
$2.78K ﹤0.01%
80
+60
+300% +$2.05K
AKAM icon
408
Akamai
AKAM
$16.8B
$2.7K ﹤0.01%
32
EEMS icon
409
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$375M
$2.65K ﹤0.01%
55
CERS icon
410
Cerus
CERS
$516M
$2.64K ﹤0.01%
723
+531
+277% +$2K
U icon
411
Unity
U
$19.3B
$2.63K ﹤0.01%
+92
New +$2.88K
FOLD
412
DELISTED
Amicus Therapeutics
FOLD
$2.63K ﹤0.01%
215
TXG icon
413
10x Genomics
TXG
$7.62B
$2.62K ﹤0.01%
+72
New +$2.35K
LH icon
414
Labcorp
LH
$26.1B
$2.59K ﹤0.01%
13
-1,806
-99% -$353K
CMCSA icon
415
Comcast
CMCSA
$91B
$2.59K ﹤0.01%
74
PACB icon
416
Pacific Biosciences
PACB
$354M
$2.58K ﹤0.01%
316
+220
+229% +$1.9K
BEAM icon
417
Beam Therapeutics
BEAM
$2.77B
$2.58K ﹤0.01%
66
+51
+340% +$2.28K
XYZ
418
Block Inc
XYZ
$47.5B
$2.58K ﹤0.01%
41
+30
+273% +$1.85K
COTY icon
419
Coty
COTY
$2.48B
$2.57K ﹤0.01%
300
PATH icon
420
UiPath
PATH
$8.14B
$2.57K ﹤0.01%
+202
New +$2.5K
SXI icon
421
Standex International
SXI
$3.97B
$2.56K ﹤0.01%
25
TWOU
422
DELISTED
2U Inc
TWOU
$2.55K ﹤0.01%
14
+10
+250% +$1.98K
CELL
423
DELISTED
PhenomeX Inc. Common Stock
CELL
$2.46K ﹤0.01%
+916
New +$2.42K
TWLO icon
424
Twilio
TWLO
$39.3B
$2.45K ﹤0.01%
+50
New +$2.85K
OSPN icon
425
OneSpan
OSPN
$601M
$2.44K ﹤0.01%
218

Similar funds

C.M. Bidwell & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, C.M. Bidwell & Associates held 553 positions worth $127M, up 5.1% from $121M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

C.M. Bidwell & Associates's Q4 2022 filing shows 80 new, 86 increased, 113 reduced and 64 closed positions. Its largest new stake was Ameriprise Financial: 1,105 shares worth $344K. The largest sale was Vanguard Russell 2000 ETF, an estimated $781K.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 7.2% a quarter earlier, followed by Healthcare and Industrials.

  • C.M. Bidwell & Associates's largest Q4 2022 buy was Ameriprise Financial: 1,105 shares worth $344K.
  • C.M. Bidwell & Associates added most to Schwab U.S Small- Cap ETF in Q4 2022, an estimated $887K increase.
  • C.M. Bidwell & Associates's biggest Q4 2022 reduction was Vanguard Russell 2000 ETF, cutting an estimated $781K.
  • C.M. Bidwell & Associates fully exited iShares Gold Trust in Q4 2022, selling an estimated $320K.
  • C.M. Bidwell & Associates's ten largest holdings make up 33% of its $127M portfolio in Q4 2022.
  • C.M. Bidwell & Associates opened 80 new positions and closed 64 in Q4 2022.
  • C.M. Bidwell & Associates's portfolio value rose 5.1% quarter-over-quarter to $127M.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2022, filed 10 Feb 2023.